๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

[18F]F-AraG

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 3 trials in our USA register that name [18F]F-AraG as an intervention. Synced 24 Sep 2026
3Trials tracked
3Recruiting now
1Lead sponsor
1Country register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

[18F]F-AraG is named as a drug or biological intervention in 3 clinical trials in our USA trial register, 3 of which are recruiting. The lead sponsor is CellSight Technologies, Inc.. Registered phase: Phase 2. Conditions studied include HIV Infections; Advanced Non Small Cell Lung Cancer; Covid19.

01

Clinical trials of [18F]F-AraG

3 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT03684655 Imaging Immune Activation in HIV by PET-MR (ClinicalTrials.gov ↗)
HIV Infections
Phase 2 Recruiting CellSight Technologies, Inc. USA
NCT04815096 Imaging Immune Activation in COVID-19 (ClinicalTrials.gov ↗)
Covid19, SARS-CoV Infection
Phase 2 Recruiting CellSight Technologies, Inc. USA
NCT06107374 Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG (ClinicalTrials.gov ↗)
Advanced Non Small Cell Lung Cancer
Phase 2 Recruiting CellSight Technologies, Inc. USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

4 conditions
Condition (as registered)Trials
HIV Infections1
Advanced Non Small Cell Lung Cancer1
Covid191
SARS-CoV Infection1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
CellSight Technologies, Inc.3
04

Trials by country register

Register[18F]F-AraG trials
Clinical trials in USA3

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how [18F]F-AraG works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists [18F]F-AraG (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.